O19.6 Use of Surfactant Vesicles as a Potential Gonococcal Vaccine Delivery System to Generate Antibody Against Neisserial Lipooligosaccharide | Sexually Transmitted Infections

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

O.19 - Prevention and curing STIs: Who is the winner?

O19.6 Use of Surfactant Vesicles as a Potential Gonococcal Vaccine Delivery System to Generate Antibody Against Neisserial Lipooligosaccharide

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Stein D, Zimmerman L, Park J, et al

O19.6 Use of Surfactant Vesicles as a Potential Gonococcal Vaccine Delivery System to Generate Antibody Against Neisserial Lipooligosaccharide

Sexually Transmitted Infections 2013;89:A64.